成纤维细胞生长因子受体2多态性与乳腺癌相关性研究(3)
 |
| 第1页 |
参见附件。
[3] Xuegong Z，Sylvia LA，Shereen E. Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 Polymorphisms and isoform Splicing in breast cancer [J]. Mol Endocrinol，2009，23(9)：1397-1405.
[4] Jirong L，Xiao-Ou S，Qiuyin C. Evaluation of breast cancer susceptibility loci in Chinese women [J]. Cancer Epidemiol Biomarkers Prev，2010，19(9)：2357-2365.
[5] Tannheimer SL，Rehemtulla A，Ethier SP. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE [J]. Breast Cancer Res，2000，2(4)：311-320.
[6] Bates CM. Role of fibroblast growth factor receptor signaling in kidney development [J]. Pediatr Nephrol，2007，22(3)：343-349.
[7] Parsa S，Ramasamy SK，De Langhe S，et al. Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling [J]. Dev Biol，2008，317(1)：121-131.
[8] Grose R，Dickson C. Fibroblast growth factor signaling in tumorigenesis [J]. Cytokine Growth Factor Rev，2005，16(2)：179-186.
[9] Kondo T，Zheng L，Liu W，et al. Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated kinase pathway to modulate thyroid cancer progression [J]. Cancer Res，2007，67(11)：5461-5470.
[10] Moffa AB，Tannheimer SL，Ethier SP. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells [J] ......
您现在查看是摘要介绍页，详见PDF附件(3689kb)。